v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT (Unaudited) - USD ($)
Total
Series A, Preferred Stock
Series B, Preferred Stock
Series C, Preferred Stock
Common Stock
Additional Paid-In Capital
Series AA Preferred Stock [Member]
Retained Earnings (Accumulated Deficit)
Balance, shares at Jun. 30, 2024   13,992,340 1,327,670 0 213,953,591   1  
Balance, amount at Jun. 30, 2024 $ (5,148,969) $ 13,992 $ 1,328 $ 0 $ 21,397 $ 57,561,804 $ 0 $ (62,747,490)
Shares issued as compensation to directors and officers, shares         12,500,000      
Shares issued as compensation to directors and officers, amount 52,500 0 0 0 $ 1,250 51,250 0 0
Shares issued for consulting services, shares         5,350,000      
Shares issued for consulting services, amount 23,270 0 0 0 $ 535 22,735 0 0
Shares issued for conversion of notes payable, shares         50,291,270      
Shares issued for conversion of notes payable, amount 211,224 0 0 0 $ 5,029 206,196 0 0
Net loss for the nine months ended March 31, 2025 (423,221) $ 0 $ 0 $ 0 $ 0 0 $ 0 (423,221)
Balance, shares at Mar. 31, 2025   13,992,340 1,327,670 0 282,094,861   1  
Balance, amount at Mar. 31, 2025 (5,285,197) $ 13,992 $ 1,328 $ 0 $ 28,211 57,841,984 $ 0 (63,170,712)
Balance, shares at Dec. 31, 2024   13,992,340 1,327,670 0 265,470,081   1  
Balance, amount at Dec. 31, 2024 (4,986,964) $ 13,992 $ 1,328 $ 0 $ 26,458 57,773,822 $ 0 (62,802,654)
Shares issued for conversion of notes payable, shares         16,624,780      
Shares issued for conversion of notes payable, amount 69,825 0 0 0 $ 1,662 68,682 0 0
Net loss for the nine months ended March 31, 2025 (368,056) $ 0 $ 0 $ 0 $ 0 0 $ 0 (368,056)
Balance, shares at Mar. 31, 2025   13,992,340 1,327,670 0 282,094,861   1  
Balance, amount at Mar. 31, 2025 (5,285,197) $ 13,992 $ 1,328 $ 0 $ 28,211 57,841,984 $ 0 (63,170,712)
Balance, shares at Jun. 30, 2025   13,992,340 1,327,670 0 368,544,861   1  
Balance, amount at Jun. 30, 2025 (5,840,865) $ 13,992 $ 1,328 $ 0 $ 36,854 58,196,429 $ 0 (64,089,470)
Shares issued as compensation to directors and officers, shares         65,000,000      
Shares issued as compensation to directors and officers, amount 337,100       $ 6,500 330,600    
Shares issued for consulting services, shares         2,250,000      
Shares issued for consulting services, amount 10,750       $ 225 10,525    
Shares issued for conversion of notes payable, shares         58,834,782      
Shares issued for conversion of notes payable, amount 180,884       $ 5,883 175,001    
Net loss for the nine months ended March 31, 2025 (1,538,406)             (1,538,406)
Shares issued as compensation to employees, shares         1,000,000      
Shares issued as compensation to employees, amount 4,300       $ 100 4,200    
Commitment shares issued pursuant to financings, shares         2,625,000      
Commitment shares issued pursuant to financings, amount 18,788       $ 263 18,525    
Balance, shares at Mar. 31, 2026   13,992,340 1,327,670 0 498,254,643   1  
Balance, amount at Mar. 31, 2026 (6,827,451) $ 13,992 $ 1,328 $ 0 $ 49,825 58,735,280 $ 0 (65,627,876)
Balance, shares at Dec. 31, 2025   13,992,340 1,327,670 0 453,919,861   1  
Balance, amount at Dec. 31, 2025 (6,387,340) $ 13,992 $ 1,328 $ 0 $ 45,393 58,591,979 $ 0 (65,040,033)
Shares issued as compensation to directors and officers, shares         16,000,000      
Shares issued as compensation to directors and officers, amount 91,200       $ 1,600 89,600    
Shares issued for conversion of notes payable, shares         26,834,782      
Shares issued for conversion of notes payable, amount 46,484       $ 2,683 43,801    
Net loss for the nine months ended March 31, 2025 (587,844)             (587,844)
Commitment shares issued pursuant to financings, amount 10,050       $ 150 9,900    
Commitment shares issued pursuant to financings, shares         1,500,000      
Balance, shares at Mar. 31, 2026   13,992,340 1,327,670 0 498,254,643   1  
Balance, amount at Mar. 31, 2026 $ (6,827,451) $ 13,992 $ 1,328 $ 0 $ 49,825 $ 58,735,280 $ 0 $ (65,627,876)